Welcome to Feed the Bull - A home for investment information and interaction.


(MILL, AFFY, RGS, CRWE) PennyOmega.com Stocks to Watch

Posted, by pennylynnomega on April 14th, 2012


http://pennyomega.com/img/mill.jpgMILL, Miller Energy Resources, Inc.

** MILL reported that it expanded its development potential in the Susitna Basin of Alaska with the addition of an oil and gas exploration license for 45,764 acres.

The new acreage is located south of the Company?s existing Licenses No. 2 and No. 4 in the Susitna Basin of Alaska.

With the addition of License No. 5, MILL controls nearly 700,000 acres of State of Alaska oil and gas lands, the largest number of acres under lease and license by any company for oil and gas exploration on state lands.

MILL is a high growth oil and natural gas exploration, production and drilling company operating in multiple exploration and production basins in North America. MILL?s focus is in Cook Inlet, Alaska and in the heart of Tennessee's prolific and hydrocarbon-rich Appalachian Basin including the Chattanooga Shale.

More about MILL at www.millerenergyresources.com


http://pennyomega.com/img/affy2.gifAFFY, Affymax, Inc.

** AFFY and Takeda Pharmaceuticals U.S.A. reported that the Centers for Medicare and Medicaid Services has granted a unique product reimbursement code, or Q-code, for OMONTYS(R) (peginesatide) Injection.

The OMONTYS-specific billing code, Q2047, will help streamline the billing process for dialysis organizations using OMONTYS. This new Q-code will become effective on July 1, 2012.

On March 27, 2012, the FDA approved OMONTYS for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is the only once-monthly erythropoiesis-stimulating agent for anemia available to the dialysis patient population in the United States.

In 2006, AFFY and Takeda Pharmaceutical Company Limited entered into an exclusive global agreement to collaborate on the development and commercialization of OMONTYS. Both companies are working together to co-commercialize OMONTYS in the U.S., while Takeda holds an exclusive license to develop and commercialize the product outside the U.S.

AFFY is a biopharmaceutical company. Its mission is to discover, develop and deliver innovative therapies that improve the lives of patients with kidney disease and other serious and often life-threatening illnesses.

More about AFFY at www.affymax.com.


http://pennyomega.com/img/rgs.jpgRGS, Regis Corporation

** RGS reported that it has entered into an agreement with members of the Provost family to sell RGS? minority ownership interest in Provalliance, the largest hair salon company in Europe.

Under the terms of the agreement, RGS will receive EUR 80 million in cash. The transaction is expected to close prior to September 30, 2012 and is subject to the Provost family securing financing for the purchase price.

RGS is the beauty industry?s global leader in beauty salons, hair restoration centers and cosmetology education.

More about RGS at www.regiscorp.com


http://pennyomega.com/img/crwenew.jpgCRWE, Crown Equity Holdings Inc., CRWE.OB

CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them.

CRWE?s advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness.

Advertising plays an important role in businesses. There are different forms of advertisements, among the proven and effective ways of advertise your business is to use different kinds of media like broadcast and print. Nowadays, internet has become one of the effective ways of advertising the business. The latest addition to the trends in internet advertisement is uploading video advertising.

http://pennyomega.com/img/crwetub.jpg CRWE Tube (www.crwetube.com), a video sharing site of CRWE, allows billions of people around the world to upload, watch and share original videos.

With online videos continuing to experience explosive, viral growth and the web rapidly moving from text to video, businesses will need to adapt to the shift in video distribution technology or quickly become irrelevant to their consumers who anticipate seeing video everywhere online

More about CRWE at www.crownequityholdings.com.



Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyOmega.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://pennyomega.com/disclaimer). Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a media-advertisement and newswire company. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.

Authored by, pennylynnomega
Log in or register to post Private Message
Advertise with us

Add new comment

By submitting this form, you accept the Mollom privacy policy.